C F Dietrich1, B Braden, M Hocke, M Ott, A Ignee. 1. Medical and Imaging Department, Caritas-Krankenhaus, Innere Medizin 2, Caritaskrankenhaus Bad Mergentheim, Uhlandstr. 7, 97980 Bad Mergentheim, Germany. christoph.dietrich@ckbm.de
Abstract
BACKGROUND: Contrast enhanced ultrasound (CEUS) is a new imaging method for detection and characterisation of liver tumours. The role of CEUS in pancreatic disease is less obvious. We prospectively evaluated CEUS for characterization of undetermined solid pancreatic lesions (gold standard histology). PATIENTS AND METHODS: A total of 112 solitary undetermined pancreatic masses (70 ductal adenocarcinoma and 42 neoplastic nodules of other origin) were prospectively examined in patients without metastatic disease using transabdominal ultrasound. Tumour enhancing features were analyzed in comparison to the surrounding pancreatic parenchyma in patients with adequate visualisation. RESULTS: The sign of iso-hypervascularity as a sign of non-ductal adenocarcinoma showed a sensitivity of 100%, specifity of 90% and accuracy of 93.8%. The sign of hypovascularity as a sign of ductal adenocarcinoma showed a sensitivity of 90%, specifity of 100% and an accuracy of 93.8%. CONCLUSION: CEUS allows differential diagnosis of ductal adenocarcinoma and non-ductal adenocarcinoma (mainly neuroendocrine tumours and (microcystic) serous pancreatic adenoma) in the most of cases.
BACKGROUND: Contrast enhanced ultrasound (CEUS) is a new imaging method for detection and characterisation of liver tumours. The role of CEUS in pancreatic disease is less obvious. We prospectively evaluated CEUS for characterization of undetermined solid pancreatic lesions (gold standard histology). PATIENTS AND METHODS: A total of 112 solitary undetermined pancreatic masses (70 ductal adenocarcinoma and 42 neoplastic nodules of other origin) were prospectively examined in patients without metastatic disease using transabdominal ultrasound. Tumour enhancing features were analyzed in comparison to the surrounding pancreatic parenchyma in patients with adequate visualisation. RESULTS: The sign of iso-hypervascularity as a sign of non-ductal adenocarcinoma showed a sensitivity of 100%, specifity of 90% and accuracy of 93.8%. The sign of hypovascularity as a sign of ductal adenocarcinoma showed a sensitivity of 90%, specifity of 100% and an accuracy of 93.8%. CONCLUSION: CEUS allows differential diagnosis of ductal adenocarcinoma and non-ductal adenocarcinoma (mainly neuroendocrine tumours and (microcystic) serous pancreatic adenoma) in the most of cases.
Authors: C F Dietrich; M S Leuschner; S Zeuzem; G Herrmann; C Sarrazin; W F Caspary; U F Leuschner Journal: Eur J Gastroenterol Hepatol Date: 1999-07 Impact factor: 2.566
Authors: K Koito; T Namieno; T Nagakawa; N Hirokawa; T Ichimura; T Syonai; N Yama; M Someya; K Nakata; K Sakata; M Hareyama Journal: Eur J Radiol Date: 2001-05 Impact factor: 3.528
Authors: Michael Hocke; Ewald Schulze; Peter Gottschalk; Theodor Topalidis; Christoph F Dietrich Journal: World J Gastroenterol Date: 2006-01-14 Impact factor: 5.742
Authors: Chakshu Sharma; Karim M Eltawil; Paul D Renfrew; Mark J Walsh; Michele Molinari Journal: World J Gastroenterol Date: 2011-02-21 Impact factor: 5.742
Authors: David G Ramirez; Mark Ciccaglione; Awaneesh K Upadhyay; Vinh T Pham; Mark A Borden; Richard K P Benninger Journal: Proc Natl Acad Sci U S A Date: 2021-10-12 Impact factor: 11.205